Advertisement

Ads Placeholder
Loading...

Marpai, Inc.

MRAINASDAQ
Healthcare
Medical - Healthcare Plans
$0.22
$-0.11(-33.33%)
U.S. Market is Open • 13:24

Marpai, Inc. Fundamental Analysis

Marpai, Inc. (MRAI) shows moderate financial fundamentals with a PE ratio of -0.31, profit margin of -91.50%, and ROE of 51.56%. The company generates $0.0B in annual revenue with weak year-over-year growth of -24.17%.

Key Strengths

ROE51.56%
PEG Ratio0.01

Areas of Concern

Operating Margin-74.78%
Cash Position2.60%
Current Ratio0.40
We analyze MRAI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -51.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-51.1/100

We analyze MRAI's fundamental strength across five key dimensions:

Efficiency Score

Weak

MRAI struggles to generate sufficient returns from assets.

ROA > 10%
-1.52%

Valuation Score

Excellent

MRAI trades at attractive valuation levels.

PE < 25
-0.31
PEG Ratio < 2
0.01

Growth Score

Moderate

MRAI shows steady but slowing expansion.

Revenue Growth > 5%
-24.17%
EPS Growth > 10%
53.62%

Financial Health Score

Moderate

MRAI shows balanced financial health with some risks.

Debt/Equity < 1
-0.02
Current Ratio > 1
0.40

Profitability Score

Weak

MRAI struggles to sustain strong margins.

ROE > 15%
51.56%
Net Margin ≥ 15%
-91.50%
Positive Free Cash Flow
No

Key Financial Metrics

Is MRAI Expensive or Cheap?

P/E Ratio

MRAI trades at -0.31 times earnings. This suggests potential undervaluation.

-0.31

PEG Ratio

When adjusting for growth, MRAI's PEG of 0.01 indicates potential undervaluation.

0.01

Price to Book

The market values Marpai, Inc. at -0.16 times its book value. This may indicate undervaluation.

-0.16

EV/EBITDA

Enterprise value stands at -0.27 times EBITDA. This is generally considered low.

-0.27

How Well Does MRAI Make Money?

Net Profit Margin

For every $100 in sales, Marpai, Inc. keeps $-91.50 as profit after all expenses.

-91.50%

Operating Margin

Core operations generate -74.78 in profit for every $100 in revenue, before interest and taxes.

-74.78%

ROE

Management delivers $51.56 in profit for every $100 of shareholder equity.

51.56%

ROA

Marpai, Inc. generates $-1.52 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.52%

Following the Money - Real Cash Generation

Operating Cash Flow

Marpai, Inc. generates limited operating cash flow of $-6.08M, signaling weaker underlying cash strength.

$-6.08M

Free Cash Flow

Marpai, Inc. generates weak or negative free cash flow of $-6.08M, restricting financial flexibility.

$-6.08M

FCF Per Share

Each share generates $-0.35 in free cash annually.

$-0.35

FCF Yield

MRAI converts -1.79% of its market value into free cash.

-1.79%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.31

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.16

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.23

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.40

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.52

vs 25 benchmark

ROA

Return on assets percentage

-1.52

vs 25 benchmark

ROCE

Return on capital employed

0.92

vs 25 benchmark

How MRAI Stacks Against Its Sector Peers

MetricMRAI ValueSector AveragePerformance
P/E Ratio-0.3128.09 Better (Cheaper)
ROE51.56%775.00% Weak
Net Margin-91.50%-45393.00% (disorted) Weak
Debt/Equity-0.020.34 Strong (Low Leverage)
Current Ratio0.402809.49 Weak Liquidity
ROA-151.87%-17931.00% (disorted) Weak

MRAI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Marpai, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-477.03%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-656.53%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ